Chest pain is a common presenting complaint in emergency department (ED) patients. While diagnosing acute coronary syndrome (ACS) is straightforward, evaluating the extent of coronary artery disease (CAD) is time and resource intensive. Routine use of outpatient stress testing does not guarantee follow-up for all patients. Computed tomography coronary angiography (CTCA) makes it possible to conduct CAD testing prior to ED discharge. The purpose of this study was to evaluate the real-world effectiveness of CTCA in ED patients with chest pain. We conducted a cohort study comparing outcomes in 100 ED patients with chest pain from a single academic center by an intention to treat analysis. One patient cohort (n=50) underwent CTCA during the index ED visit while the other cohort (n=50) was given a prescription for an outpatient stress test. Comparisons were made of the duration of ED visit, the completion of CAD testing, and 3-month adverse events (return ED visit for chest pain, myocardial infarction, or death). Standard statistical methods for comparing continuous and categorical variables were used. Differences in baseline characteristics were negligible. The CT cohort was older (mean age 47.0 years versus 41.3 in control, p = 0.009) and mean BMI in both cohorts was in the obese range (31.5 kg/m2 for the CT cohort, 31.6 kg/m2 for control, p = 0.94) CAD testing was completed in significantly more patients in the CT cohort (48 patients versus 18 patients in the control cohort, p < 0.0001). For 2 CT patients, scanner malfunction resulted in no scan being performed, while in control patients, 32 failed to complete follow-up testing. Three CTCA studies were nondiagnostic due to excessive artifacts. Median CAC was 0 Agatston units (interquartile range [IQR] 0 - 1.5) and 34 patients (71% of 48 with successful CTCA) had a CAC score of zero. Detection of CAD was significantly higher in the CT cohort (14 patients versus 1 patient in the control cohort, p = 0.0004). Obstructive CAD (> 50% stenosis of a coronary artery) was found in 6 CT patients and only 1 control patient (p = 0.11). Median duration of stay was 417.5 minutes (IQR 359 - 581) in the CT cohort and 400 minutes (IQR 338 - 471) in the control cohort (p = 0.53). Patient subgroups were evaluated based on their time of ED arrival, but no subgroup had significantly different duration of stay. During 3 months of follow-up, four patients in each cohort were reevaluated in the ED for chest pain, while no patients suffered MI or death. The routine use of CTCA for evaluating ED patients with chest pain dramatically improves completion of CAD testing without any significant effect on the duration of stay. The prevalence of CAD in the tested population is notable and the majority of patients with CAD will go undetected using a strategy of routine outpatient follow-up stress testing. After ruling out ACS, patients can likely be discharged safely with expected 3-month event rates to be low. Further study is necessary to determine if greater accuracy in CTCA detecting CAD could reduce adverse outcomes, return ED visits, and redundant workups for chest pain.